{
  "report_rows": [
    {
      "kpi": "Operating diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.04 vs. cons $1.019",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Distribution ending rate base",
      "prediction": "IN-LINE",
      "answer": "pred ~$15.05B vs. cons $15.03B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Capital expenditures",
      "prediction": "BEAT",
      "answer": "pred ~$1.05B vs. cons $1.04B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 EPS guidance ($8.40-$8.50 range)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.45 midpoint vs. cons $8.452",
      "confidence": "LOW"
    },
    {
      "kpi": "FY27 APT/Waha commentary",
      "prediction": "LOWER",
      "answer": "guide: moderation vs. UNVERIFIED consensus",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -0.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -1.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 Waha normalization drives estimate/multiple risk",
  "day5_confidence": "LOW"
}